Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
278.25 USD | +0.70% |
|
+0.39% | +18.25% |
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Revenues | 220M | 493M | 844M | 1.04B | 1.83B | |||||
Total Revenues | 220M | 493M | 844M | 1.04B | 1.83B | |||||
Cost of Goods Sold, Total | 25.06M | 78.05M | 140M | 169M | 310M | |||||
Gross Profit | 195M | 415M | 704M | 869M | 1.52B | |||||
Selling General & Admin Expenses, Total | 534M | 658M | 702M | 771M | 796M | |||||
R&D Expenses | 600M | 585M | 711M | 883M | 1B | |||||
Other Operating Expenses, Total | 1.13B | 1.24B | 1.41B | 1.65B | 1.8B | |||||
Operating Income | -939M | -828M | -709M | -785M | -282M | |||||
Interest Expense, Total | - | -84.5M | -143M | -156M | -121M | |||||
Interest And Investment Income | 33.45M | 11.81M | 1.58M | 24.81M | 95.56M | |||||
Net Interest Expenses | 33.45M | -72.69M | -141M | -131M | -25.66M | |||||
Other Non Operating Income (Expenses) | 9.44M | -8.52M | -57.74M | -101M | -109M | |||||
EBT, Excl. Unusual Items | -897M | -910M | -908M | -1.02B | -417M | |||||
Gain (Loss) On Sale Of Investments | 11.29M | 54.04M | 55.7M | -33.31M | -16.94M | |||||
In Process R&D Expenses | - | - | - | - | - | |||||
Legal Settlements | - | - | - | - | - | |||||
Other Unusual Items | - | - | - | -76.59M | - | |||||
EBT, Incl. Unusual Items | -885M | -856M | -852M | -1.13B | -434M | |||||
Income Tax Expense | 863K | 2.68M | 680K | 4.16M | 6.72M | |||||
Earnings From Continuing Operations | -886M | -858M | -853M | -1.13B | -440M | |||||
Net Income to Company | -886M | -858M | -853M | -1.13B | -440M | |||||
Net Income - (IS) | -886M | -858M | -853M | -1.13B | -440M | |||||
Net Income to Common Incl Extra Items | -886M | -858M | -853M | -1.13B | -440M | |||||
Net Income to Common Excl. Extra Items | -886M | -858M | -853M | -1.13B | -440M | |||||
Per Share Items | ||||||||||
Net EPS - Basic | -8.11 | -7.46 | -7.2 | -9.3 | -3.52 | |||||
Basic EPS - Continuing Operations | -8.11 | -7.46 | -7.2 | -9.3 | -3.52 | |||||
Basic Weighted Average Shares Outstanding | 109M | 115M | 118M | 122M | 125M | |||||
Net EPS - Diluted | -8.11 | -7.46 | -7.2 | -9.3 | -3.52 | |||||
Diluted EPS - Continuing Operations | -8.11 | -7.46 | -7.2 | -9.3 | -3.52 | |||||
Diluted Weighted Average Shares Outstanding | 109M | 115M | 118M | 122M | 125M | |||||
Normalized Basic EPS | -5.13 | -4.94 | -4.79 | -5.22 | -2.08 | |||||
Normalized Diluted EPS | -5.13 | -4.94 | -4.79 | -5.22 | -2.08 | |||||
Supplemental Items | ||||||||||
EBITDA | -922M | -794M | -661M | -741M | -228M | |||||
EBITA | -939M | -828M | -709M | -785M | -282M | |||||
EBIT | -939M | -828M | -709M | -785M | -282M | |||||
EBITDAR | -832M | -679M | -535M | -723M | -161M | |||||
Total Revenues (As Reported) | 220M | 493M | 844M | 1.04B | 1.83B | |||||
Effective Tax Rate - (Ratio) | -0.1 | -0.31 | -0.08 | -0.37 | -1.55 | |||||
Current Domestic Taxes | -394K | 61K | 293K | - | 4.02M | |||||
Current Foreign Taxes | 3.23M | 5.84M | 3.15M | 5.6M | 3.42M | |||||
Total Current Taxes | 2.84M | 5.9M | 3.45M | 5.6M | 7.44M | |||||
Deferred Domestic Taxes | 394K | 393K | - | - | - | |||||
Deferred Foreign Taxes | -2.37M | -3.61M | -2.77M | -1.43M | -713K | |||||
Total Deferred Taxes | -1.98M | -3.22M | -2.77M | -1.43M | -713K | |||||
Normalized Net Income | -560M | -569M | -567M | -636M | -260M | |||||
Interest on Long-Term Debt | - | - | 143M | 48.37M | 14.67M | |||||
Supplemental Operating Expense Items | ||||||||||
General and Administrative Expenses | - | - | - | - | - | |||||
Research And Development Expense From Footnotes | 655M | 655M | 792M | 883M | 1B | |||||
Net Rental Expense, Total | 90.43M | 115M | 126M | 17.61M | 66.64M | |||||
Imputed Operating Lease Interest Expense | - | 82.09M | 76.45M | 9.16M | 24.41M | |||||
Imputed Operating Lease Depreciation | - | 33.07M | 49.78M | 8.45M | 42.23M | |||||
Stock-Based Comp., R&D Exp. (Total) | 88.93M | 60.46M | 68.42M | 92.16M | 97.27M | |||||
Stock-Based Comp., G&A Exp. (Total) | - | - | - | - | - | |||||
Stock-Based Comp., SG&A Exp. (Total) | 85.91M | 79.41M | 97.3M | 138M | 124M | |||||
Stock-Based Comp., Other (Total) | - | - | - | - | - | |||||
Total Stock-Based Compensation | 175M | 140M | 166M | 231M | 222M |